Last reviewed · How we verify

NCT07157215: NIV-SAFETY

An International Survey on the Use of NIV Outside the ICU

Recruiting now Last updated 30 September 2025
What this trial tests

trial in Non-invasive Ventilation in 400 participants. Currently enrolling.

Timeline
16 September 2025
Primary endpoint
15 March 2026
15 March 2026

Quick facts

Lead sponsorDr. Ram Manohar Lohia Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment400
Start date16 September 2025
Primary completion15 March 2026
Estimated completion15 March 2026
Sites1 location across India

Conditions studied

Sponsor

Dr. Ram Manohar Lohia Hospital

Who can join

18 and older, any sex, with Non-invasive Ventilation or Intensive Care (ICU). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-invasive ventilation (NIV) is a way to support breathing using a mask or helmet instead of a breathing tube, and it is proven to reduce the need for intubation, save lives, shorten hospital stays, and lower costs. While NIV has long been used in intensive care units, it is now increasingly applied in emergency rooms, hospital wards, and long-term care facilities. However, global data on how it is used outside ICUs-such as which patients receive it, how well it works, and what barriers exist-is lacking. The NIV-Safety Study is a worldwide survey of doctors, nurses, and respiratory therapists to understand current practices, outcomes, and challenges of NIV use beyond the ICU. The findings aim to guide safer, more effective, and standardized use of NIV across different healthcare settings.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Non-invasive Ventilation

Currently open trials in the same condition.

Other Dr. Ram Manohar Lohia Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07157215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing